Porous Silicon Nanoneedles Efficiently Deliver Adenine Base Editor to Correct a Recurrent Pathogenic COL7A1 Variant in Recessive Dystrophic Epidermolysis Bullosa

Documenti analoghi

• Narrowing the Differential: A Unique Case of Dystrophic Epidermolysis Bullosa
  di: Lauren Yacobucci, et al.
  Pubblicazione: (2025)
• First Report of Homozygous COL7A1 c.5756delG Mutation Causing Recessive Dystrophic Epidermolysis Bullosa in a Non‐Consanguineous Japanese Family
  di: Nozomi Kohama, et al.
  Pubblicazione: (2025)
• Bibliometric Analysis of the 50 Most Cited Publications in Epidermolysis Bullosa
  di: Evelyn F. Fagan, et al.
  Pubblicazione: (2025)
• Off‐Label Use of Double‐Dose Beremagene Geperpavec (B‐ VEC ) in the Treatment of Recessive Dystrophic Epidermolysis Bullosa: A Promising Clinical Case
  di: Melissa M. Yamada, et al.
  Pubblicazione: (2025)
• The Clinical Efficacy and Safety of Dupilumab Monotherapy in Dystrophic Epidermolysis Bullosa: A Retrospective Real‐World Study
  di: Jian-Bo Wang, et al.
  Pubblicazione: (2026)